What is the recommended dosage of Lisinopril (Angiotensin-Converting Enzyme inhibitor) for hypertension and heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Dosing for Hypertension and Heart Failure

For hypertension, start lisinopril at 10 mg once daily and titrate to a usual maintenance dose of 20-40 mg daily; for heart failure, start at 2.5-5 mg once daily and titrate to a target dose of 30-35 mg daily. 1

Hypertension Dosing

Initial Therapy

  • Start with 10 mg once daily in most patients with hypertension 1
  • If the patient is already on diuretics, reduce the starting dose to 5 mg once daily 1
  • Titrate the dose upward at intervals of not less than 2 weeks based on blood pressure response 2

Target Maintenance Dose

  • The usual maintenance range is 20-40 mg once daily 1
  • Doses up to 80 mg have been studied but do not provide greater efficacy 1
  • If blood pressure remains uncontrolled on lisinopril alone, add a low-dose diuretic (e.g., hydrochlorothiazide 12.5 mg) rather than exceeding 40 mg 1

Heart Failure Dosing

Starting Dose

  • Begin with 5 mg once daily when used with diuretics and digitalis for systolic heart failure 1
  • In patients with hyponatremia (serum sodium <130 mEq/L), start at 2.5 mg once daily 1
  • The European Society of Cardiology recommends starting at 2.5 mg daily for all heart failure patients 2

Target Dose

  • Titrate to a target of 30-35 mg once daily as tolerated 2, 3
  • Maximum dose is 40 mg once daily 1
  • Higher doses (32.5-35 mg daily) significantly reduce mortality and hospitalization compared to low doses (2.5-5 mg daily) in the ATLAS trial 2

Titration Strategy

  • Double the dose at intervals of not less than 2 weeks 2
  • Aim for the target dose or the highest tolerated dose - remember that some ACE inhibitor is better than none 2
  • Diuretic doses may need adjustment during titration to minimize hypotension 1

Post-Myocardial Infarction Dosing

  • In hemodynamically stable patients within 24 hours of MI, give 5 mg orally, then 5 mg after 24 hours, 10 mg after 48 hours, then 10 mg once daily 2, 1
  • For patients with low systolic blood pressure (≤120 mmHg and >100 mmHg), start with 2.5 mg 2, 1
  • Continue therapy for at least 6 weeks 1

Renal Impairment Adjustments

  • No dose adjustment needed if creatinine clearance >30 mL/min 1
  • For creatinine clearance 10-30 mL/min: reduce initial dose by 50% (hypertension: 5 mg; heart failure: 2.5 mg; post-MI: 2.5 mg) 1
  • For hemodialysis or creatinine clearance <10 mL/min: start at 2.5 mg once daily 1

Monitoring Requirements

Initial Monitoring

  • Check serum potassium and creatinine after 5-7 days of starting therapy 2
  • Recheck every 5-7 days during titration until potassium values are stable 2

Ongoing Monitoring

  • Monitor blood pressure, renal function, and electrolytes 1-2 weeks after each dose increment 2, 3
  • Check at 3 months, then every 6 months thereafter 2, 3

Acceptable Changes

  • An increase in creatinine up to 50% above baseline, or to 3 mg/dL (266 μmol/L), whichever is greater, is acceptable 2, 3
  • Asymptomatic hypotension does not require dose adjustment 2

Important Precautions

Avoid or Seek Specialist Advice When:

  • Significant renal dysfunction (creatinine >2.5 mg/dL or >221 μmol/L) 2
  • Hyperkalemia (potassium >5.0 mmol/L) 2
  • Symptomatic or severe hypotension (systolic BP <90 mmHg) 2

Drug Interactions to Avoid

  • Avoid NSAIDs and COX-2 inhibitors - they can worsen renal function and reduce ACE inhibitor efficacy 2
  • Avoid potassium-sparing diuretics during initiation unless specifically needed for persistent hypokalemia 2
  • Consider withholding diuretics for 24 hours before starting therapy to minimize first-dose hypotension 2

Common Pitfalls

Underdosing in Heart Failure

  • Many clinicians fail to titrate to target doses - the ATLAS trial clearly demonstrated that higher doses (30-35 mg daily) reduce hospitalizations by 24% and the combined endpoint of death or hospitalization by 12% compared to low doses 2, 4
  • The appearance of hypotension after the initial dose does not preclude careful subsequent titration 1

Cough Management

  • Cough is common in heart failure patients and may not be drug-related 2
  • ACE inhibitor-induced cough rarely requires discontinuation 2
  • Only switch to an angiotensin receptor blocker if cough is proven to be ACE inhibitor-related through withdrawal and rechallenge 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lisinopril Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.